Rosiglitazone prevents murine hepatic fibrosis induced by Schistosoma japonicum

Abstract

The activation of PPAR gamma by its ligand can retard liver fibrosis and suggest the use of rosiglitazone for the treatment of liver fibrosis due to Schistosoma japonicum infection.